ADMA BIOLOGICS, INC. — Director's Dealing 2012

Jul 19, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ADMA BIOLOGICS, INC. (NONE)
CIK: 0001368514
Period of Report: 2012-07-17

Reporting Person: Guiheen Lawrence P. (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-07-17	Options to purchase	$9.60	A	13258	Acquired	2022-07-17	Common Stock (13258)	Direct

Footnotes

F1: These options vest over four years with 25% vesting on July 17, 2013, and the remaining 75% vesting in equal monthly installments over the next 36 months.